The bottom line is Neurtrope is the only game in town for moderate to severe alzheimer's. Not only is the bar low, essentially a 3 month stabilization in SIB scores before tracking the same downward slope as Namenda, but its also a much quicker path and requires many fewer patients. Results from current trial are expected per CEO this summer.
News 
Market Data 
Discover 
